SIAPS’ role to control malaria was recently featured in Health & Humanitarian: The Supply Chain Review. Between 2000 and 2015, malaria case incidences declined by 41% and mortality rates by 62%. However, approximately 212 million people were infected and 429,000 people died in 2015, with the majority being children under the age of 5 in […]
Archive | EthiopiaRSS feed for this section
SIAPS has received funding from the US President’s Malaria Initiative (PMI) to work in eight countries—Angola, Burundi, Democratic Republic of the Congo (DRC), Ethiopia, Kenya, Guinea, Mali, and South Sudan—to strengthen pharmaceutical systems for improved malaria control. This report synthesizes the pharmaceutical systems strengthening efforts of SIAPS and documents how the approach was used to support efforts to control malaria.
Defeating malaria through pharmaceutical systems strengthening: A review of SIAPS’s activities in eight countries
SIAPS recently published the results of its activities in eight countries (Angola, Burundi, the Democratic Republic of the Congo (DRC), Ethiopia, Kenya, Guinea, Mali, and South Sudan) to control malaria. This report summarizes systems strengthening interventions that support the prevention and treatment of malaria. With funding from the US President’s Malaria Initiative (PMI) and based […]
Project dates: September 2011- March 2017
On 17 March 2017, SIAPS Ethiopia held a closing ceremony in Addis Ababa. Guests from partner government and non-government organizations, USAID, universities and health facilities were present at the event and expressed their appreciation for the systems strengthening work SIAPS has done in Ethiopia. SIAPS has been in Ethiopia for the last five years working […]
This report presents results of the assessment on implementation of Auditable Pharmaceutical Transaction and Services (APTS), a package of interventions designed to improve the quality of pharmaceutical services at public health facilities. The development and implementation of this intervention has been supported by the SIAPS program, which is implemented by Management Sciences for Health (MSH) with funding from United States Agency for International Development (USAID). The project is implemented in close collaboration with the Federal Ministry of Health (FMOH), regional health bureaus (RHBs), and the respective health facilities.
Ethiopian National Health Insurance Scale-Up Assessment on Medicines Financing, Use, and Benefit Management
An assessment on current pharmaceutical financing, SHI and CBHI medicines coverage, and public and private sector medicines prescribing and dispensing and their costs was conducted. The SCMS program conducted an assessment that addressed the supply chain and public-private partnership implications of the expected increased demand for quality medicines and related health supplies.
This report presents the findings from the SIAPS assessment, the implications for preparing a proof of concept for launching and implementing the SHI scheme, and the potential for opportunities to engage the private sector.
A new collection of technical briefs highlight strategic approaches, innovations, results and lessons learned in implementing systems-wide interventions to strengthen pharmaceutical systems and services in three countries: South Africa, Namibia and Ethiopia. Click on the thumbnails below to read the full technical briefs. Strengthening Namibia’s Pharmacy Sector and Workforce Strengthening the Leadership and Management of […]
By Tsion Issayas, Communications Manager for SIAPS Ethiopia. This post originally appeared on MSH’s website. Aster Amanuel Desalegn lives in Debre Markos, 190 miles from the Ethiopian capital of Addis Ababa. She is a 70-year-old mother of four and grandmother of two. Her granddaughters, Emuye, 6, and Blen, 8, live with her. On a trip back […]
Over the past two decades, Ethiopia has improved its delivery of primary health care services and begun to make great progress toward meeting the Millennium Development Goals, particularly with regard to maternal, newborn, and child health and the prevention and control of HIV and tuberculosis. Yet pharmaceutical services—a patient’s last point of care and one […]
The primary goal of the SIAPS TB Core portfolio was to ensure the availability of quality pharmaceutical products and support […]
- Rapport de quantification des produits de la santé reproductive, maternelle, néonatale et infantile pour la période de janvier 2017 à décembre 2020
La présente activité avait pour objectif d’apporter un soutien au Ministère de la Santé et de l’Hygiène publique (MSHP) pour […]
Project dates: September 2012 – December 2016